Vol. 92 No. 3 (2023)

Published: 2023-09-28

Full Issue

PDF

Editorial Note

Final ORBIS project conference

Marcin Skotnicki, Janina Lulek
- PDF

Invited Editorials

ORBIS project – where have we arrived?

Marcin Skotnicki, Emilia Jakubowska, Wojciech Smułek, Sharon Davin, Lidia Tajber, Janina Lulek

e936
- PDF

Original Papers

New therapies targeting aging cells in the skin

Anna Paszel-Jaworska, Justyna Gornowicz-Porowska, Aleksandra Dańczak-Pazdrowska, Adriana Polańska, Violetta Krajka-Kuźniak, Maciej Stawny, Aleksandra Gostyńska, Michał Masternak, Błażej Rubiś

e903
- PDF

Review Papers

Insights into solid dosage forms with nonlinear optical imaging

Teemu J. Tomberg, Alba Maria Arbiol Enguita , Clare J. Strachan

e914
- PDF
Recent advances in drug substance development – prodrug strategies for enhancing the bioavailability and potency of antiviral nucleosides

Andrzej Kutner

e878
- PDF
Real-time quality control for chemical and biotechnological processes: a brief review

Agnieszka Kołodziejczak-Radzimska, Beata Rukowicz, Sharon Davin

e901
- PDF
Impact of ORBIS on public policies – open consultations of draft regulatory documents and the Pharmaceutical Strategy for Europe

Piotr J. Rudzki, Olga Czerepow-Bielik, Marta Karaźniewicz-Łada

e890
- PDF
Effect of moisture on solid state stability

Stanko Srčič, Zoran Lavrič

e908
- PDF
Emerging Technologies Transforming Therapy

Edward Weaver, Dimitrios Lamprou

e859
- PDF
Energy efficient smart manufacturing of pharmaceutical solid oral dosage forms

Ashley Dan, Rohit Ramachandran

e893
- PDF

Thousand words about...

Senescent cells as new pharmacological targets for age-related diseases and anti-aging therapy

Michal M. Masternak

e907
- PDF
Future Opportunities in the Field of Drug Delivery Research

Joachim Kohn, Bozena Michniak-Kohn

e925
- PDF
Overcoming the barrier of skin to drug permeation for localized dermatological therapies

Bozena Michniak-Kohn, Joachim Kohn

e926
- PDF